[Optimization and safety assessment of Akkermansia muciniphila for human administration]

Med Sci (Paris). 2017 Apr;33(4):373-375. doi: 10.1051/medsci/20173304002. Epub 2017 May 12.

[Article in French]

Authors

Hubert Plovier¹, Patrice D Cani¹

Affiliation

¹ Université catholique de Louvain, Louvain drug research institute LDRI, WELBIO (Walloon excellence in lifesciences and biotechnology), groupe de recherche en métabolisme et nutrition, avenue E. Mounier, 73 B1.73.11, B-1200 Bruxelles, Belgique.

PMID: 28497729
DOI: 10.1051/medsci/20173304002

No abstract available

Publication types

News

MeSH terms

Calibration
Dietary Supplements / adverse effects
Dietary Supplements / standards
Gastrointestinal Microbiome / physiology
Humans
Metabolic Syndrome / diet therapy*
Metabolic Syndrome / microbiology
Patient Safety / standards
Probiotics* / administration & dosage
Probiotics* / adverse effects
Risk Assessment
Verrucomicrobia / physiology*